Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference 2021-09-27 19:20
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC 2021-09-27 19:02
GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea 2021-09-27 18:35
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis 2021-09-27 17:37
Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level 2021-09-27 16:20
Clever Culture Systems Appoints Thermo Fisher Scientific as Exclusive US APAS® Distributor 2021-09-27 16:00
Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002 2021-09-27 08:30
Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting 2021-09-27 08:00
Kintor Pharma Announces Brazil's ANVISA Approves Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients 2021-09-26 23:09
GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target 2021-09-26 22:28
JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) 2021-09-26 20:00
Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit 2021-09-26 10:12
Qiming's Portfolio Company Broncus Lists on Main Board of HKEx 2021-09-24 14:10
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 14:09
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206 2021-09-24 13:56
Broncus Lists on Main Board of HKEx 2021-09-24 11:52
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA 2021-09-24 09:18
Johnson & Johnson Innovation Announces Awardees of the Digital Technologies of Tomorrow QuickFire Challenge 2021-09-24 09:02
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases 2021-09-24 08:47
Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis 2021-09-24 08:00
1 342 343 344 345 346 896